Showing results (41-50 of 134) with videos related to
Sort By:
Pageof 14
Vaccines|January 23, 2020
Novel Nested Peptide Epitopes Recognized by CD4+ T Cells Induced by HIV-1 Conserved-Region VaccinesNicola Borthwick, Sandra Silva-Arrieta, Anuska Llano, et al.AIDS Research and Human Retroviruses|July 29, 2003
Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopesM Sohrab Hossain, Hiroko Tomiyama, Takafumi Inagawa, et al.Journal of Immunological Methods|February 4, 2009
A rapid and efficient strategy to generate allele-specific anti-HLA monoclonal antibodiesSatoshi Yamazaki, Nao Suzuki, Tsuneyoshi Saito, et al.Journal of Virology|November 3, 2022
Immunological Control of HIV-1 Disease Progression by Rare Protective HLA AlleleYu Zhang, Takayuki Chikata, Nozomi Kuse, et al.Journal of Virology|July 20, 2012
HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absentTakuya Naruto, Hiroyuki Gatanaga, George Nelson, et al.Ebiomedicine|April 9, 2019
Priming of HIV-1-specific CD8+ T cells with strong functional properties from naïve T cellsNozomi Kuse, Xiaoming Sun, Tomohiro Akahoshi, et al.Plos One|October 20, 2010
Failure of effector function of human CD8+ T Cells in NOD/SCID/JAK3⁻/⁻ immunodeficient mice transplanted with human CD34+ hematopoietic stem cellsYoshinori Sato, Hiroshi Takata, Naoki Kobayashi, et al.Human Immunology|November 7, 2009
Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individualsMasao Hashimoto, Mitsutaka Kitano, Kazutaka Honda, et al.AIDS (London, England)|February 18, 2010
Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistanceHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.Microbes and Infection|December 10, 2008
Escape mutation selected by Gag28-36-specific cytotoxic T cells in HLA-A*2402-positive HIV-1-infected donorsHirokazu Koizumi, Tomomi Iwatani, Junko Tanuma, et al.Pageof 14